Try our beta test site

Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter

This study has been terminated.
(Funding Stopped)
Information provided by (Responsible Party):
C. R. Bard Identifier:
First received: June 1, 2009
Last updated: June 13, 2016
Last verified: June 2016
The study will test a hypothesis that the RIVS system will have a higher rate of successful first PIV placement compared to conventional catheter without a significant increase in complications and time of procedure.

Condition Intervention
Vascular Access Complication
Device: RIVS vascular access
Device: Conventional vascular access

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Evaluation of the Safety and Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter for Peripheral Intravenous (PIV) Insertion in Children, Oncology Patients and Elderly: a Controlled Randomized Trial

Further study details as provided by C. R. Bard:

Primary Outcome Measures:
  • First attempt IV success rate, time of procedure [ Time Frame: Immediate peri-procedure ]

Secondary Outcome Measures:
  • Number of attempts required to complete a successful IV start [ Time Frame: Immediate peri-procedure ]

Enrollment: 175
Study Start Date: June 2009
Study Completion Date: August 2013
Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: RIVS vascular access
RIVS vascular access
Device: RIVS vascular access
Access to peripheral vasculature
Active Comparator: Conventional vascular access
Conventional vascular access
Device: Conventional vascular access
Vascular access using conventional venous access device

Detailed Description:
The hypothesis to be statistically tested was that the RIVS system will have a higher rate of successful first attempt peripheral intravenous placement success as compared to conventional peripheral intravenous catheters without a significant increase in device related complications and procedure time.

Ages Eligible for Study:   5 Years to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria

  • Any type of oncology patients undergoing chemotherapy or post-chemotherapy (without a port/cannula), or over 65 years
  • Requires peripheral IV as determined by examining physician
  • Requires the IV when a study nurse or resident is available
  • Able to sign an informed consent

Exclusion Criteria

  • Active systemic or cutaneous infection or inflammation;
  • Pre-existing immunodeficiency disorder and/or chronic use of systemic steroids;
  • Known, significant history of bleeding diathesis, coagulopathy, von Willebrand's disease or current platelet count < 100,000 cells/mm3, baseline INR ≥1.8, or fibrinogen level less than 150 mg/dl (if received a fibrinolytic agent within prior 24 hours);
  • Currently involved in any other investigational clinical trials;
  • Previous vascular grafts or surgery at the target vessel access site;
  • Females who are pregnant, planning to become pregnant within 3 months of the procedure, or lactating;
  • Central line available
  • Requirement for immediate IV placement (patient's condition would potentially be compromised if there is a time delay in IV placement)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00914069

United States, California
Washington Outpatient Surgery Center
Fremont, California, United States, 94538
United States, Florida
St. Vincent's Medical Center
Jacksonville, Florida, United States, 32204
United States, Ohio
University Hospital Case Medical Center
Cleveland, Ohio, United States, 44106
Sponsors and Collaborators
C. R. Bard
Principal Investigator: Jeffrey S Stuart, MD Washington Outpatient Surgery Center
  More Information

Responsible Party: C. R. Bard Identifier: NCT00914069     History of Changes
Other Study ID Numbers: 62009123
Study First Received: June 1, 2009
Last Updated: June 13, 2016 processed this record on March 28, 2017